Takeda Pharmaceutical Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Christophe Weber
Chief executive officer
JP¥2.1b
Total compensation
CEO salary percentage | 15.2% |
CEO tenure | 10yrs |
CEO ownership | 0.05% |
Management average tenure | 6.7yrs |
Board average tenure | 8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2024 | JP¥2b | JP¥317m | JP¥144b |
Dec 31 2023 | n/a | n/a | JP¥178b |
Sep 30 2023 | n/a | n/a | JP¥192b |
Jun 30 2023 | n/a | n/a | JP¥301b |
Mar 31 2023 | JP¥2b | JP¥295m | JP¥317b |
Dec 31 2022 | n/a | n/a | JP¥275b |
Sep 30 2022 | n/a | n/a | JP¥213b |
Jun 30 2022 | n/a | n/a | JP¥197b |
Mar 31 2022 | JP¥2b | JP¥281m | JP¥230b |
Dec 31 2021 | n/a | n/a | JP¥439b |
Sep 30 2021 | n/a | n/a | JP¥473b |
Jun 30 2021 | n/a | n/a | JP¥431b |
Mar 31 2021 | JP¥2b | JP¥267m | JP¥376b |
Dec 31 2020 | n/a | n/a | JP¥181b |
Sep 30 2020 | n/a | n/a | JP¥56b |
Jun 30 2020 | n/a | n/a | JP¥120b |
Mar 31 2020 | JP¥2b | JP¥273m | JP¥44b |
Dec 31 2019 | n/a | n/a | JP¥13b |
Sep 30 2019 | n/a | n/a | JP¥83b |
Jun 30 2019 | n/a | n/a | JP¥64b |
Mar 31 2019 | JP¥2b | JP¥269m | JP¥135b |
Dec 31 2018 | n/a | n/a | JP¥110b |
Sep 30 2018 | n/a | n/a | JP¥141b |
Jun 30 2018 | n/a | n/a | JP¥120b |
Mar 31 2018 | JP¥1b | JP¥254m | JP¥187b |
Compensation vs Market: Christophe's total compensation ($USD12.95M) is above average for companies of similar size in the German market ($USD5.28M).
Compensation vs Earnings: Christophe's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Christophe Weber (58 yo)
10yrs
Tenure
JP¥2,083,000,000
Compensation
Mr. Christophe Weber has been the President and Chief Executive Officer of Takeda Pharmaceutical Company Limited since June 27, 2014 and April 2015 respectively and served as its Chief Operating Officer fr...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 10yrs | JP¥2.08b | 0.050% ¥ 19.0m | |
Chair of Management Board | no data | no data | no data | |
CFO & Director | less than a year | no data | 0.00084% ¥ 319.1k | |
Member of Management Board | no data | no data | no data | |
Member of Management Board and Head of R&D Global Science & Biomedical Policy | no data | no data | no data | |
Chief Accounting Officer & Corporate Controller | no data | no data | no data | |
Senior Vice President of Corporate Finance & Controlling Department | 11.3yrs | no data | no data | |
Chief Data & Technology Officer | 2.3yrs | no data | no data | |
Global Head of Investor Relations & Global Finance | 3.8yrs | no data | no data | |
Global General Counsel | 9.7yrs | no data | no data | |
Chief Ethics & Compliance Officer | 9.7yrs | no data | no data | |
Chief Human Resources Officer | 3.4yrs | no data | no data |
6.7yrs
Average Tenure
51.5yo
Average Age
Experienced Management: TKD's management team is seasoned and experienced (6.7 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 10yrs | JP¥2.08b | 0.050% ¥ 19.0m | |
CFO & Director | no data | no data | 0.00084% ¥ 319.1k | |
President of Research & Development and Representative Director | 9yrs | JP¥972.00m | 0.0088% ¥ 3.4m | |
Independent External Director | 2yrs | JP¥32.00m | no data | |
Independent External Director | 5.4yrs | JP¥44.00m | 0.00026% ¥ 98.8k | |
Independent External Director | 8yrs | JP¥49.00m | 0.00016% ¥ 60.8k | |
Independent External Director | 8yrs | JP¥40.00m | 0.00080% ¥ 303.9k | |
Independent External Director | 5.4yrs | JP¥44.00m | 0.000070% ¥ 26.6k | |
Independent External Director | 5yrs | JP¥38.00m | no data | |
Independent External Director | 8yrs | JP¥46.00m | no data | |
Independent External Chair | 3yrs | JP¥43.00m | no data | |
Independent External Director | 8yrs | JP¥43.00m | 0.00064% ¥ 243.1k |
8.0yrs
Average Tenure
66.5yo
Average Age
Experienced Board: TKD's board of directors are considered experienced (8 years average tenure).